CTI BioPharma Corp. (DE) Common Stock

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Cerevel Therapeutics appointed Susan Altschuller, as Chief Financial Officer. The company’s stock has a 52-week high of $41.46 . RSI Value: 71.46 CERE Price Action: Shares of Cerevel Therapeutics rose 4.7% to close at $34.00 on Monday. Voyager Therapeutics, Inc. (NASDAQ: VYGR) Voyager Therapeutics reported a year-over-year increase in first-quarter EPS and sales results. “Voyager started 2023 by ...

Related tickers: ACAD, CTIC, MMSI, CERE, VYGR.

Upgrades According to Macquarie, the prior rating for Lufax Holding Ltd (NYSE:LU) was changed from Underperform to Outperform. For the fourth quarter, Lufax Holding had an EPS of $0.05, compared to year-ago quarter EPS of $0.19. The current stock performance of Lufax Holding shows a 52-week-high of $7.05 and a 52-week-low of $1.26. Moreover, at the end of the last trading period, the closing price was at $1.64. Barrington Research upgraded the previous rating for Warner Bros. Discovery Inc (NASDAQ:WBD) from Market Perform to Outperform. For the first quarter, Warner Bros. Discovery had an EPS of $0.44, compared to year-ago quarter EPS of $0.69. The current stock performance of Warner Bros. Discovery shows a 52-week-high of $18.76 and a 52-week-low of $8.82. Moreover, at the end of the last trading period, the closing price was at $12.81. According to Exane BNP Paribas, the prior rating for NEXTracker Inc (NASDAQ:NXT) was changed from Neutral to Outperform. At the moment, the stock has a 52-week-high of $40.50 and a 52-week-low of $28.24. NEXTracker closed at $40.32 at the end of the last trading period. Argus Research upgraded the previous rating for Royal Caribbean Group (NYSE:RCL) from Hold to Buy. Royal Caribbean Gr earned $0.23 in the first quarter, compared to $4.57 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.38 and a 52-week-low of $31.09. Royal Caribbean Gr closed at $76.12 at the end of the last trading period. According to Argus Research, the prior rating for Canadian Pacific Kansas City Ltd (NYSE:CP) was changed from Hold to Buy. For the first quarter, Canadian Pacific Kansas had an EPS of $0.90, compared to year-ago quarter EPS of $0.53. The current stock performance of Canadian Pacific Kansas shows a 52-week-high of $83.18 and a 52-week-low of $65.22. Moreover, at the end of the last trading period, the closing price was at $82.93. Keefe, Bruyette & Woods upgraded the previous rating for Ellington Financial Inc (NYSE:EFC) from Market Perform to Outperform. In the first quarter, Ellington Financial showed an EPS of $0.45, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.37 and a 52-week-low of $10.81. Ellington Financial closed at $12.46 at the end of the last trading period. Deutsche Bank upgraded the previous rating for Veris Residential Inc (NYSE:VRE) from Hold to Buy. In the first quarter, Veris Residential showed an EPS of $0.15, compared to $0.09 from the year-ago quarter. The current stock performance of Veris Residential shows a 52-week-high of $17.69 and a 52-week-low of $10.21. Moreover, at the end of the last trading period, the closing price was at $16.24. According to Gordon Haskett, the prior rating for Expedia Group Inc (NASDAQ:EXPE) was changed from Hold to Buy. For the first quarter, Expedia Group had an EPS of $0.20, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $135.35 and a 52-week-low of $82.39. Expedia Group closed at $92.23 at the end of the last trading period. For NovoCure Ltd (NASDAQ:Full story available on Benzinga.com

Related tickers: EFC, PB, PB, CBSH, NEO, COIN, NEO, CTIC, VRE, EXPE, NVCR, GILD, PLMR, AMX, LU, CFR, ABST, CP, NGMS, DOX, VOR, RCL, AMBP, RYN, GEHC, WBD, WMB, NXT.